Back to Search
Start Over
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure.
- Source :
-
Leukemia & lymphoma [Leuk Lymphoma] 2024 Sep; Vol. 65 (9), pp. 1378-1380. Date of Electronic Publication: 2024 May 15. - Publication Year :
- 2024
- Subjects :
- Humans
Treatment Outcome
Male
Aged
Female
Middle Aged
Antineoplastic Agents pharmacokinetics
Antineoplastic Agents therapeutic use
Prognosis
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell mortality
Leukemia, Lymphocytic, Chronic, B-Cell diagnosis
Quinazolinones pharmacokinetics
Quinazolinones therapeutic use
Quinazolinones administration & dosage
Purines pharmacokinetics
Purines therapeutic use
Purines administration & dosage
Lymphoma, Follicular drug therapy
Lymphoma, Follicular mortality
Lymphoma, Follicular diagnosis
Subjects
Details
- Language :
- English
- ISSN :
- 1029-2403
- Volume :
- 65
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Leukemia & lymphoma
- Publication Type :
- Academic Journal
- Accession number :
- 38747179
- Full Text :
- https://doi.org/10.1080/10428194.2024.2353330